
Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt:A2JMZC) is looking forward to bringing its clinical expertise and evidence from Khiron-owned Zerenia Clinics in Colombia, Peru, Brazil, and the UK to Spanish patients to guide medical professionals for the benefit of Spanish patients.
Spain has been an important exporter of medical cannabis in Europe, but Spain itself has not had national medical cannabis legislation in place. With a population of more than 47 million people in Spain, experts in the medical cannabis industry in Europe estimate that the potential market size for the medical cannabis market is at least 700,000 patients or 1.5% of the country's total population.